Literature DB >> 21163500

Immunosuppression-induced bronchial epithelial-mesenchymal transition: a potential contributor to obliterative bronchiolitis.

Valerie M Felton1, Landon J Inge, Brigham C Willis, Ross M Bremner, Michael A Smith.   

Abstract

OBJECTIVE: Obliterative bronchiolitis is the predominant histopathologic finding in patients with chronic rejection after lung transplant. This fibroproliferative transformation within small airways of lung allograft is poorly understood; however, studies suggest epithelial-mesenchymal transition plays a role. Transplant immunosuppressive therapy has been shown to cause epithelial-mesenchymal transition in renal tubular epithelial cells, with subsequent fibrosis. This study explored whether immunosuppressive therapy contributes to epithelial-mesenchymal transition in airway epithelial cells.
METHODS: Bronchial epithelial cell line RL-65 was treated 3 to 5 days with several immunosuppressive agents, including cyclosporine (INN ciclosporin), tacrolimus, azathioprine, mycophenolic acid, sirolimus, prednisone, and transforming growth factor β1 as control. We then analyzed cells for presence of mesenchymal morphology and protein markers.
RESULTS: Treatment with cyclosporine, azathioprine, mycophenolate, and sirolimus resulted in elongated and irregular cell shape, and all but azathioprine showed loss of cell-cell adhesions relative to vehicle-treated cells. Expressions of extracellular matrix proteins, fibronectin and collagen, along with mesenchymal marker, vimentin, were significantly upregulated. Immunofluorescence showed loss of E-cadherin at cell membranes and cytoskeletal rearrangements typical of epithelial-mesenchymal transition. These immunosuppressive agents also increased transforming growth factor produced by cells; however, tacrolimus- and prednisone-treated cells maintained epithelial morphology, baseline levels of matrix protein expression, and transforming growth factor production levels.
CONCLUSIONS: Overall, we found that certain immunosuppressive agents may contribute to partial epithelial-mesenchymal transition in bronchial epithelial cells, specifically increasing production of excessive extracellular matrix proteins. This may provide novel insights into the pathogenesis of obliterative bronchiolitis after lung transplant. Copyright Â
© 2011 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21163500     DOI: 10.1016/j.jtcvs.2010.10.006

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

Review 1.  Diagnosis, Pathophysiology and Experimental Models of Chronic Lung Allograft Rejection.

Authors:  Jason M Gauthier; Daniel Ruiz-Pérez; Wenjun Li; Ramsey R Hachem; Varun Puri; Andrew E Gelman; Daniel Kreisel
Journal:  Transplantation       Date:  2018-09       Impact factor: 4.939

2.  Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation.

Authors:  Paola Tomei; Valentina Masola; Simona Granata; Gloria Bellin; Pierluigi Carratù; Miriam Ficial; Valentina Anna Ventura; Maurizio Onisto; Onofrio Resta; Giovanni Gambaro; Marco Chilosi; Antonio Lupo; Gianluigi Zaza
Journal:  J Nephrol       Date:  2016-03-29       Impact factor: 3.902

Review 3.  Adverse effects of immunosuppressant drugs upon airway epithelial cell and mucociliary clearance: implications for lung transplant recipients.

Authors:  Rogerio Pazetti; Paulo Manuel Pêgo-Fernandes; Fabio Biscegli Jatene
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

4.  In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets.

Authors:  Simona Granata; Gloria Santoro; Valentina Masola; Paola Tomei; Fabio Sallustio; Paola Pontrelli; Matteo Accetturo; Nadia Antonucci; Pierluigi Carratù; Antonio Lupo; Gianluigi Zaza
Journal:  Int J Mol Sci       Date:  2018-04-20       Impact factor: 5.923

5.  Epithelial to mesenchymal transition in endomyocardial biopsies from orthotopic heart transplant recipients.

Authors:  Bistees George; Maria Del Mar Rivera Rolon; Sharma Mohit; Heather L Stevenson
Journal:  BMJ Case Rep       Date:  2019-08-22

6.  MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction.

Authors:  Naofumi Miyahara; Alberto Benazzo; Felicitas Oberndorfer; Akinori Iwasaki; Viktoria Laszlo; Balasz Döme; Mir Ali Hoda; Peter Jaksch; Walter Klepetko; Konrad Hoetzenecker
Journal:  Transpl Int       Date:  2022-01-13       Impact factor: 3.782

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.